Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 10/20 | 0.40 |
| ▸ | SRC | P12931 | 7/20 | 0.39 |
| ▸ | LYN | P07948 | 6/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.37 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | TYK2 | P29597 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.35 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24557248 | 1.00 | BTK (0.40) | BTKSRCLYNHPGDPIK3CA | |
| SCHEMBL29638318 | 0.85 | BTK (0.53) | BTKSRCLYNHPGDTYK2 | |
| SCHEMBL29638463 | 0.85 | AR (0.47) | BTKLYNSLC22A12 | |
| SCHEMBL24557291 | 0.85 | AR (0.47) | BTKLYNSLC22A12 | |
| SCHEMBL29638483 | 0.84 | BTK (0.40) | BTKSRCLYNHPGDCDK4 | |
| SCHEMBL24557323 | 0.83 | AR (0.49) | SLC22A12 | |
| SCHEMBL29638343 | 0.83 | AR (0.49) | SLC22A12 | |
| SCHEMBL29638427 | 0.83 | SLC22A12 (0.45) | SLC22A12TYK2 | |
| SCHEMBL24557301 | 0.82 | BTK (0.45) | BTKSRCLYN | |
| SCHEMBL29638446 | 0.82 | BTK (0.45) | BTKSRCLYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022136914-A1 | TYK2 INHIBITORS AND USES THEREOF | SUDO BIOSCIENCES LIMITED (GB) | 2022-06-30 | — | — | WO | disclosed |